Trials / Sponsors / ESSA Pharmaceuticals
ESSA Pharmaceuticals
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC Prostate Cancer | Phase 1 / Phase 2 | 2021-12-21 |
| Terminated | Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer Prostate Cancer | Phase 1 | 2020-06-23 |
| Terminated | Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer Prostatic Neoplasms, Genital Neoplasms, Male, Genital Diseases, Male | Phase 1 / Phase 2 | 2015-10-01 |